Greg Winter

Title: The Innovative Contributions of Greg Winter

Introduction

Greg Winter is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of methods for selecting functional polypeptides. With a total of 4 patents to his name, Winter's work has had a profound impact on the scientific community.

Latest Patents

One of Winter's latest patents is a method to screen phage display libraries with different ligands. This invention provides a method for selecting a population of functional polypeptides that bind a target ligand in a first binding site and a generic ligand in a second binding site. The generic ligand is capable of binding functional members of the repertoire regardless of target ligand specificity. The method involves contacting the repertoire with the generic ligand and selecting functional polypeptides bound thereto, followed by contacting the selected functional polypeptides with the target ligand to select a population of polypeptides that bind to the target ligand. This innovative approach allows for preselection of a polypeptide repertoire based on functionality, enhancing the efficiency of further selection processes.

Career Highlights

Throughout his career, Greg Winter has worked with notable companies such as Domantis Limited and Boehringer Mannheim GmbH. His expertise in biotechnology and polypeptide selection has positioned him as a leader in his field.

Collaborations

Some of his notable coworkers include Ian M Tomlinson and Hiroshi Ueda. Their collaborative efforts have contributed to advancements in the biotechnology sector.

Conclusion

Greg Winter's innovative methods and contributions to biotechnology have established him as a key figure in the field. His patents reflect a commitment to advancing scientific knowledge and improving methodologies in polypeptide selection.